STEP has a continued commitment to providing the latest treatment guidelines and treatment information. In the past few months, several people have requested the updated or revised guidelines for HIV infection. Here are links to these important resources:
Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
An update from the April 2001 version of the guidelines and all revisions, this version covers such areas of HIV treatment as considerations for initiating therapy in asymptomatic patients and new cautions regarding interruptions of therapy (so-called drug holidays). Also among the updates, the combination of didanosine and lamivudine has been added to the "Strongly Recommended" category.
Click here for PDF.
Use of Antiretroviral Agents in Pediatric HIV Infection
The guidelines address the pediatric-specific issues associated with antiretroviral treatment and provide guidance to health care providers caring for infected infants, children, and adolescents. Sections that have been updated include "Treatment Recommendations," "Choice of Initial Antiretroviral Therapy," "Available Antiretroviral Drugs," and the "Appendix on Characteristics of Available Antiretroviral Drugs."
For the updated version of both guidelines, please go to: http://hivatis.org/trtgdlns.html or the National AETC Resource Center at http://aids-ed.org. Revisions are highlighted on the Web versions.
If you have any questions in regard to the new guidelines, you may call the STEP Talkline at 1-877-597-STEP.